fda glp-1 compounding During GLP‑1 shortages, expanded to help meet patient needs. With supply stabilizing, guidance has shifted—highlighting why it's important to understand how compounded medications differ from FDA‑approved options. Learn more in FDA Intensifies Crackdown on GLP-1

Patients should be counseled to: Consume smaller, more frequent meals (56 per day) rather than large portions Emphasize low-fat, low-fiber foods that empty more readily from the stomach Ensure adequate hydration, particularly with liquid calories if solid food tolerance is poor Avoid lying down immediately after meals Chew food thoroughly and eat slowly For patients developing concerning symptoms, temporary dose reduction or treatment interruption may be necessary

Geographic disparities are stark, with 23 states reporting adult obesity rates of 35% or higher ^28

The risk: They are betting that human nature will defeat pharmacology

Typical weight loss using this product in a weight management program is 1-2 lbs

Buteau J, Foisy S, Joly E, Prentki M